The bitcoin halving is imminent, and crypto is on everyone’s mind this week.That’s because the technical event, which happens every four years and serves...
NEUILLY-SUR-SEINE, France–(BUSINESS WIRE)–Regulatory News:
Pioneer in TV digitalisation in France, M6 Group (Paris:MMT) pursues its ambition regarding the streaming and presents today its new platform...
Strong growth in sales driven by the $3m (~€2.8m) milestone payment from NuVasive during H1 2023
Acceleration in sales of the Kheiron system (+40% vs....
The U.S. Securities and Exchange Commission (SEC) recently faced a significant cybersecurity challenge when its account on the social media platform X (formerly known...
CLERMONT-FERRAND, France & LYON, France–(BUSINESS WIRE)–Regulatory News:
AFYREN (Paris:ALAFY), a greentech company that offers manufacturers bio-based, low-carbon products made using technology based on natural micro-organisms,...
Cryptocurrencies continue to gain significant attention. This digital money, devoid of a central regulatory authority, opens avenues for a new and decentralized economy. Investment...
AFYREN NEOXY: Improvements underway and new targets for operations:
Start of continuous production in 2024 and break-even in 2025
Development continues in France and abroad
Finances are...
The Company announces a new identity for its iBiopsy® AI/ML tech-based suite of software as medical devices (SaMD), and business unit.
iBiopsy® becomes eyonis™.
eyonis™ brand...
CER-001 treatment attenuated systemic inflammation, downregulated Indoleamine-2,3-dioxygenase (IDO1) thereby reducing neuroactive metabolites and waste accumulation
Preclinical data support the concept that the use of CER-001...
AI Theater Presentation: “Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD”
Median’s teams will be at booth #4465, South Hall Level 3, to present the latest...